Baseline characteristics of the study population
| Characteristic . | Median (range) or N (%) . |
|---|---|
| Age, y | 23 y (14-49) |
| >29 | 22 (23.2%) |
| 14-24 | 55 (57.8%) |
| 25-39 | 35 (36.8%) |
| >39 | 5 (5.2%) |
| Female/male | 39 (41.1%)/56 (58.9%) |
| Overweight/obesity∗ | 33 (34.7%)/11 (11.6%) |
| Leukemia phenotype | B cell: 88 (92.6%)/T cell: 7 (7.4%) |
| CD20+ | 36 of 68 (52%) |
| White blood cell count (× 109/μL) | 20.0 (0.29-427.7) |
| Hyperleukocytosis | 38 (40.9%) |
| CNS disease at diagnosis | 2 (2.1%) |
| Karyotype | |
| Normal | 81 (72.6%) |
| High risk | 14 (14.8%) |
| Characteristic . | Median (range) or N (%) . |
|---|---|
| Age, y | 23 y (14-49) |
| >29 | 22 (23.2%) |
| 14-24 | 55 (57.8%) |
| 25-39 | 35 (36.8%) |
| >39 | 5 (5.2%) |
| Female/male | 39 (41.1%)/56 (58.9%) |
| Overweight/obesity∗ | 33 (34.7%)/11 (11.6%) |
| Leukemia phenotype | B cell: 88 (92.6%)/T cell: 7 (7.4%) |
| CD20+ | 36 of 68 (52%) |
| White blood cell count (× 109/μL) | 20.0 (0.29-427.7) |
| Hyperleukocytosis | 38 (40.9%) |
| CNS disease at diagnosis | 2 (2.1%) |
| Karyotype | |
| Normal | 81 (72.6%) |
| High risk | 14 (14.8%) |
Overweight is a body mass index ≥25 kg/m2; obesity is a body mass index ≥30 kg/m2.